It’s been over eight months since the COVID-19 pandemic crisis struck, changing every facet of life as we knew it. The U.S. biomedical research enterprise was not spared, as lockdowns and severe restrictions on activities took hold across the country. At the time, we offered our perspectives on efforts we could take to cushion the shock. Since that time, much has happened. COVID-19 research has blossomed with impressive results including FDA approval of a therapeutic agent (remdesivir, which was found to have value in a large-scale NIH-funded trial), development of several candidate vaccines that have already made to pivotal Phase 3 trials, and the rapid development of a variety of diagnostic testing platforms. However, research unrelated to COVID has seen a different picture.
Not to worry, the entire conference is still available to you on the event platform until Nov 19! The only thing missing is the immediate access to staff that the “live” event offered. Recordings of the presentations and related materials, as well as a plethora of resources from the Institute and Center Exhibit Hall booths await your exploration.
NIH (including help desks) will be closed on Thursday, November 26, 2020, for the federal holiday (Thanksgiving Day).
NIH (including help desks) will be closed on Wednesday, November 11, 2020, for the federal holiday (Veterans Day).
Conducting research involving human subjects during COVID? Read here for information on requesting an exception to the use of a single IRB.
NIH released a Guide Notice to inform the extramural research community how NIH is implementing the Office for Human Research Protections (OHRP)’s determination of Exception to the Single IRB Review Requirements for Certain HHS-Conducted or -Supported Cooperative Research Activities Subject to the 2018 Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.
The NIH Public Access Compliance Monitor (PACM) provides an institution with the current compliance status of all journal articles that are associated with the institution that fall under the NIH Public Access Policy.
Today, nearly twenty years after the publication of the Final NIH Statement on Sharing Research Data in 2003, we have released a Final NIH Policy for Data Management and Sharing. This represents the agency’s continued commitment to share and make broadly available the results of publicly funded biomedical research. We hope it will be a critical step in moving towards a culture change, in which data management and sharing is seen as integral to the conduct of research. Responsible data management and sharing is good for science; it maximizes availability of data to the best and brightest minds, underlies reproducibility, honors the participation of human participants by ensuring their data is both protected and fully utilized, and provides an element of transparency to ensure public trust and accountability.
Dawn Corbett, NIH’s Inclusion Policy Officer, shares why human subjects’ protection and monitoring plans are important in this next NIH’s All About Grants podcast. We will discuss what should be included in these plans as part of your application, what should be left out, what are risks and what are benefits to study participants, how reviewers assess it all, and so much more.
Researchers, if You Received a Survey, Please Provide Us with Your Perspective on the Impact of COVID-19
Since March, COVID-19 has greatly impacted the way we all work. NIH has been tracking how well our policies meet the needs of our research community in response to the ongoing pandemic. To get a better understanding of how COVID-19 is impacting our extramural researchers, we launched the Impact of COVID-19 on Extramural Researchers Survey in mid-October. If you received an invitation to take this survey, please take 15-20 minutes to complete it. This survey will be open until Friday, November 13th. The results from the survey will inform policy and program decisions, so participation is critical.
From shifting public health needs to the unprecedented pace of biomedical discovery, everything about the coronavirus response is evolving. This goes for the NIH-Wide Strategic Plan for COVID-19 Research as well, so too must it evolve.
We want your help on the next iteration of the Plan. A Request For Information released yesterday seeks public feedback on the current Plan (NOT-OD-21-018). You or your organization can submit ideas here by December 7, 2020.